2 results
8-K
EX-99.1
INVA
Innoviva, Inc.
9 Sep 13
Other Events
12:00am
UMEC/VI
125/25
(N=226)
UMEC
(N=227)
Placebo
(N=109)
Total
Age, years
Males, n (%)
Ethnicity, n (%)
Hispanic/Latino
Not Hispanic/Latino
Smoking
8-K
EX-99.11
INVA
Innoviva, Inc.
4 Sep 12
Other Events
12:00am
-group repeat dose study.
ยท Subjects with severe renal impairment (n=9; creatinine clearance (CrCL): <30 mL/min) and matched (by gender, ethnicity
- Prev
- 1
- Next